Advertisement
Canada markets closed

  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • Bitcoin CAD

    83,239.83
    -2,812.73 (-3.27%)
     

  • CMC Crypto 200

    1,259.00
    -99.01 (-7.29%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     

  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     
MARKETS LIVE BLOG:

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

Orexigen (OREX) Shows Strength: Stock Gains 11.1%

Zacks Equity Research

Orexigen Therapeutics, Inc. (OREX) was a big mover last session with its shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $3.27 to $4.26.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Orexigen currently holds a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked biomedical stocks worth considering are Medivation, Inc. (MDVN), Ligand Pharmaceuticals Inc. (LGND) and Halozyme Therapeutics, Inc. (HALO). All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




OREXIGEN THERAPEUTICS INC (OREX): Free Stock Analysis Report

MEDIVATION INC (MDVN): Free Stock Analysis Report

LIGAND PHARMACEUTICALS (LGND): Free Stock Analysis Report

HALOZYME THERAPEUTICS INC (HALO): Free Stock Analysis Report


Zacks Investment Research